| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $5.5M | — | +12.9% |
| Cost of Revenue | $499K | — | -0.6% |
| Gross Profit | $5.0M | — | +14.4% |
| R&D Expense | $1.2M | — | -3.6% |
| SG&A Expense | $3.2M | — | -6.1% |
| Operating Income | $542K | — | +255.7% |
| Pre-tax Income | $636K | — | +300.0% |
| Income Tax | $0 | — | — |
| Net Income | $636K | — | +300.0% |
| EPS (Basic) | $0.03 | — | +250.0% |
| EPS (Diluted) | $0.03 | — | +250.0% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $10.1M | +4.3% | +95.5% |
| Accounts Receivable | $5.7M | +70.6% | -23.5% |
| Current Assets | $16.7M | +20.0% | +23.4% |
| Total Assets | $27.1M | +10.7% | +10.4% |
| Current Liabilities | $5.6M | +47.4% | -19.8% |
| Total Liabilities | $5.6M |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $445K | — | -40.7% |
| Capital Expenditures | $33K | — | +266.7% |
| Investing Cash Flow | -$33K | — | +80.9% |
| Financing Cash Flow | $0 | — | +100.0% |
| Free Cash Flow | $412K | — | -44.4% |
| -19.8% |
| Stockholders' Equity | $21.5M | +4.0% | +22.3% |